Friday, October 24, 2025
1:00-5:00 PM CT
The Platform Conference Center
320 South Canal Street, Chicago, Illinois, USA

Please join us for the in-person Collaborative Myositis Groups Summit to learn about recent initiatives of IMACS as well as CARRA, iMyoS, MCTC, MIHRA, and PReS JDM. The summit’s aim is to allow members to share information, learn more about research opportunities, and enhance international collaborations.

Registration

Advance registration is required. On-site registration will not be offered. All attendees should be registered members of IMACS and/or another myositis collaborative group participating in the summit.

Register Now

A registration fee of $35.00 applies to myositis collaborative group members to defray catering and meeting expenses. No fee applies to trainee members, although pre-registration is still required.

Agenda Overview

Download final summit agenda with additional details.

  • 12:30 PM CT: Check-in opens and poster set-up begins
  • 1:00 PM CT: Main meeting begins
  • 1:15 PM CT: Collaborative Myositis Groups Updates and Selected Projects
  • 3:10 PM CT: Mentoring Program
  • 3:15 PM CT: Lightning Poster Session
  • 3:30 PM CT: Break and Poster Session
  • 4:15 PM CT: Topic of special interest, panel, and discussion
    • Standardized Interoperable Data Collection for Myositis Research
  • 5:10 PM CT: Closing remarks and adjournment
  • 5:15 PM CT: Networking hour with beverages and appetizers, supported by Lead Sponsor Priovant Therapeutics

Posters

  • iMyoS – The International Myositis Society, Jens Schmidt, MD
  • Classification of Myositis – Setting the Stage for a Universal Terminology, Margherita Giannini, MD, PhD and Jens Schmidt, MD
  • Appropriateness and Feasibility of Outcome Measures in IIM, Kaveh Ardalan, MD, MS
  • Magnetic Resonance Imaging for Adult Idiopathic Inflammatory Myopathies: A Scoping Review of Protocols, Grading Systems, and Applications, Siamak Moghadam-Kia, MD   
  • Systematic Review of Measurement Properties of Outcome Measures in Idiopathic Inflammatory Myopathies, Didem Saygin, MD
  • International Consensus Evidence-based Exercise Guideline (ICEER), Lesley Saketkoo, MD, MPH
  • Cross-Community Query into Barriers and Feasibility of Longitudinal Study Participation
    Lesley Saketkoo, MD, MPH
  • Psychological Impact and Well-Being Cross-collaborative Scientific Working Group, Aviya Levy, MD and Lesley Saketkoo, MD, MPH
  • Genetic and Biochemical Insights into Severe Calcinosis in Systemic Sclerosis and Dermatomyositis, Christian Lood, PhD
  • CARRA Calcinosis Workgroup Update, Dawn Wahezi, MD, MS
  • Updates on the CARRA Registry: Data Completeness/Quality/Critical Variable Selection, Kaveh Ardalan, MD, MS
  • Gaps in Training and Expertise in Myositis Outcome Measures, Kaushik Reddy, MBBS
  • Global Patterns and Challenges in Patient Recruitment for IIM Trials, Iris Tang, MBBS, MRCP
  • Standardizing Definitions of ILD Progression in IIM, Jisna Paul, MBBS
  • Efficacy and Safety of Brepocitinib in Patients with Active Dermatomyositis: Results from a Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III (VALOR) Trial, Julie Paik MD, MHS

Committee Meeting Faculty

Thank you to committee members Bianca Lang, Galina Marder (Chair), Lisa Rider (IMACS Coordinator), Kelly Rouster-Stevens (Vice-Chair), Sara Sabbagh (Vice-Chair), Didem Saygin.

Contact committee leaders with questions about the program, or interest in getting involved in IMACS and other groups. Email Galina Marder, MD and Kelly Rouster-Stevens, MD, PharmD.

The IMACS Meeting Committee also prepares a booklet with IIM highlights taking place at ACR Convergence. Download the 2025 guide to myositis at ACR.

Virtual Info

The Oct. 24 meeting is only offered for live and in-person attendance.

There is also a live and virtual International Myositis Assessment and Clinical Studies Group (IMACS) IMACS Annual Meeting. This takes place on Microsoft Teams on Monday, November 10, 2025 from 8:00 AM-2:00 PM ET. Details and registration for the Nov. 10 virtual meeting have been posted to the IMACS website and email list.

Acknowledgments

Thank you to our speakers and poster presenters.

The support of Lead Sponsor Priovant Therapeutics and Sponsor Abcuro is gratefully acknowledged.

TMA proudly partners with Cure JM Foundation to host this summit.

Are you interested in funding additional trainees, or supporting this important scientific gathering? Sponsorships are available at $3,500. Email tma@myositis.org.

Questions? Contact TMA Executive Director Paula Eichenbrenner.

We look forward to seeing you in Chicago!